Roxithromycin

罗红霉素

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameRoxithromycin
Drug Alias NameroxithromycineroxitromicinaroxithromycinumAssoralRulid +[10] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsRespiratory Tract DiseasesCommunicable Diseases
Global Approved IndicationsCommunicable Diseases
Approved Indications in ChinaCommunicable Diseases
Original Approved Country/TerritoryN/A
Original Approved Date1986/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenyang Hongqi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenyang Hongqi Pharmaceutical Co Ltd
Inactive CompaniesPrince Of Songkla University
Active IndicationsCommunicable Diseases
Inactive IndicationsRespiratory Tract Diseases

Other Information

ATC CodeJ01FA06
Related LinksWikipediaDrugBankKEGG